The 20 Best Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors Near Me in Durham, NC

I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Stefanovic is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Hematology , and American Board Of Internal Med, Medical Oncology.

Robin Hardie is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. She has been practicing medicine for over 28 years. Dr. Hardie is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Colorectal Cancer. Dr. Hardie is board certified in American Board Of Internal Med, Medical Oncology and American Board Of Internal Med, Hematology.

I see patients with blood related cancers, primarily lymphoma. I provide them with comprehensive care from the time they come in for diagnosis until they are cured. Duke is special because I can bring the power of a large medical center with expertise across disciplines together for the care of each patient. One of the nicest parts of my job is the Christmas cards I receive from patients that I’ve treated. For many patients who are doing well, we discharge them from the clinic after five years. The Christmas cards give me the opportunity to see that they are getting on with their lives and to hear about how their families are doing. Outside of work, my wife and I spend a lot of our free time with our two daughters and their children. We like the beach, biking and hiking as a family. Dr. Diehl is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Diehl is board certified in American Board Of Internal Med, Hematology/Oncology , American Board Of Internal Med, Internal Medicine , and American Board Of Internal Med, Medical Oncology.

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.

I have over twenty years of experience as a hematologist-oncologist focusing in hematologic malignancies, leukemias, lymphomas, myeloma, and myelodysplastic and myeloproliferative syndromes. My patient care philosophy stresses interactive discussions with patients and their families on what to expect from the illness and treatment options, making sure that all their concerns and questions are addressed. Caring for patients with cancer is complex and my care team is dedicated to helping patients with the family, social, emotional, and financial issues, in addition to compassionate medical care. Dr. Kirby is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Hairy Cell Leukemia (HCL), Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kirby is board certified in American Board Of Internal Med, Hematology.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. De Castro Iii is board certified in American Board Of Internal Med, Internal Medicine.

I was drawn to the field of oncology because cancer is a terrifying diagnosis for most people. It is one of those health issues that make people very nervous. I find great satisfaction working with cancer patients to help allay their fears and provide the best care possible. For me, it is rewarding to work with individuals who express so much courage in overcoming a difficult diagnosis. It is very rare that a patient comes alone to an appointment. Usually they have a spouse, son or daughter, a brother or sister, or a mother or father accompanying them. I spend a lot of time answering family member’s questions, who often provide a significant amount of care and support for their loved one. My job is to help educate both the patient and the family and to formulate a plan by which we can provide comprehensive care for all of the patient’s needs. Dr. Kelsey is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Kelsey is board certified in American Board Of Radiology, Radiation Oncology.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Choi is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Medical Oncology , and American Board Of Internal Med, Hematology.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft. Dr. Horwitz is board certified in American Board Of Internal Med, Medical Oncology.

Brian Allen is a Radiologist practicing medicine in Durham, North Carolina. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Ascites, Lymphofollicular Hyperplasia, Colonic Malakoplakia, and Cholangiocarcinoma (Bile Duct Cancer).

Sandeep Dave is a Hematologist and an Oncologist practicing medicine in Durham, North Carolina. Dr. Dave is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, and Bone Marrow Aspiration.

Megan Sterlina is an Oncologist practicing medicine in Chapel Hill, North Carolina. Dr. Sterlina is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Classical Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Small Lymphocytic Lymphoma (SLL).

Natalie Grover is an Oncologist practicing medicine in Chapel Hill, North Carolina. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Anne Beaven is a Hematologist practicing medicine in Chapel Hill, North Carolina. Dr. Beaven is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Christopher Dittus is an Internal Medicine provider practicing medicine in Chapel Hill, North Carolina. Dr. Dittus is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Waldenstrom Macroglobulinemia, B-Cell Lymphoma, and Bone Marrow Aspiration.

Jonathan Serody is a Hematologist practicing medicine in Chapel Hill, North Carolina. Dr. Serody is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Triple-Negative Breast Cancer, Bone Marrow Transplant, and Bone Marrow Aspiration.

Mary Tolle is a Physician Assistant practicing medicine in Carrboro, North Carolina. Ms. Tolle is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her clinical expertise encompasses Smoldering Multiple Myeloma, Marginal Zone Lymphoma (MZL), Classical Hodgkin Lymphoma, and ALK-Positive Non-Small Cell Lung Cancer.